Brand Name: | AllTest |
Model Number: | Panel(DZO-X14) |
MOQ: | 500 |
Supply Ability: | 100 Million a year |
A rapid Panel test for the qualitative detection of Zolpidem CE certified with specimen of Powder
Applications:
The Zolpidem Rapid Test Panel is a rapid chromatographic immunoassay for the qualitative detection of Zolpidem at a cut-off 50ng/ml.
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Description:
Zolpidem (brand names Ambien, Ambien CR, Intermezzo, Stilnox, Stilnoct, Sublinox, Hypnogen, Zonadin, Sanval and Zolsana) is a prescription medication used for the treatment of insomnia and some brain disorders.1 It is a short-acting nonbenzodiazepine hypnotic of the imidazopyridine class.1
That potentiates GABA, an inhibitory neurotransmitter, by binding to GABA receptors at the same location as benzodiazepines.2 It works quickly, usually within 15 minutes, and has a short half-life of two to three hours.
Zolpidem may be detected in blood or plasma to confirm a diagnosis of poisoning in hospitalized patients, provide evidence in an impaired driving arrest, or to assist in a medico-legal death investigation. Blood or plasma Zolpidem concentrations are usually in a range of 30–300 μg/l in persons receiving the drug therapeutically, 100–700 μg/l in those arrested for impaired driving, and 1000–7000 μg/l in victims of acute overdosage. Analytical techniques, in general, involve gas or liquid chromatography.3,4,5
The ZOL Rapid Test Panel is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of Zolpidem in urine. The ZOL Rapid Test Panel yields a positive result when Zolpidem in urine reaches 50ng/ml.
How to use?
Allow the test, urine specimen, and/or controls to reach room temperature (15-30ºC) prior to testing.
INTERPRETATION OF RESULTS
(Please refer to the illustration above)
NEGATIVE:* A colored line appears in the Control region (C) and colored lines appear in the Test region (T). This negative result means that the concentrations in the sample are below the designated cut-off levels for a particular drug tested.
*NOTE: The shade of the colored lines(s) in the Test region (T) may vary. The result should be considered negative whenever there is even a faint line.
POSITIVE: A colored line appears in the Control region (C) and NO line appears in the Test region (T). The positive result means that the drug concentration in the sample is greater than the designated cut-off for a specific drug.
INVALID: No line appears in the Control region (C). Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for Control line failure. Read the directions again and repeat the test with a new test card. If the result is still invalid, contact your manufacturer.